about
Neuropsychiatric lupus: a mosaic of clinical presentationsIs narcolepsy a classical autoimmune disease?Evidence for the use of intravenous immunoglobulins--a review of the literature.Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.Vitamin D and autoimmune thyroid diseasesEstimated glomerular filtration rate in a population with normal to mildly reduced renal function as predictor of cardiovascular disease.16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus.Transverse myelitis and vaccines: a multi-analysis.Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro.Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects.Exercise blood pressure and the risk for future hypertension among normotensive middle-aged adults.Is autoimmunology a discipline of its own? A big data-based bibliometric and scientometric analyses.Olfaction, psychiatric disorders and autoimmunity: is there a common genetic association?Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study.Olfaction--a window to the mind.Infections and autoimmunity--friends or foes?Hydroxychloroquine: from malaria to autoimmunity.Infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review.The 2014 ACR annual meeting: a bird's eye view of autoimmunity in 2015.Pharmacologic management of neuropsychiatric lupus.Exercise systolic blood pressure variability is associated with increased risk for new-onset hypertension among normotensive adults.Metabolic syndrome, obesity, and the risk of cancer development.Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays.Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.Anti-BLyS Treatment of 36 Israeli Systemic Lupus Erythematosus Patients.T helper 17 polarization in familial Mediterranean fever.Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever.Serum amyloid A levels in kidney-transplanted patients with familial Mediterranean fever-amyloidosis.Protracted rheumatic manifestations in travelers.Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts.Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice.HLA-DRB1 the notorious gene in the mosaic of autoimmunity.Obesity and exercise-induced ectopic ventricular arrhythmias in apparently healthy middle aged adults.Transverse Myelitis Activation Post-H1N1 Immunization: A Case of Adjuvant Induction?Narcolepsy--genes, infections and vaccines: the clues for a new autoimmune disease.Chronic illnesses in travelers to developing countries.Familial Mediterranean fever and incidence of cancer An analysis of 8534 patients with 258,803 person-years.Use of exercise capacity to improve SCORE risk prediction model in asymptomatic adults.Abnormal olfactory function demonstrated by manganese-enhanced MRI in mice with experimental neuropsychiatric lupus.Ethnic variation in toxicity and outcome of adjuvant chemoradiation for gastric cancer in Israel.
P50
Q27027588-37F9E246-59B8-4DC7-B860-1BA1702FA3D8Q30369139-60C34DAE-2CB9-488C-8893-5F5995FA10A8Q33385332-67147CBE-59E5-4B86-907D-0A3FB3F532ACQ33417409-0ABE5E99-570B-42F5-BEDC-15CBFA541FD1Q33577498-FA10037F-9279-41C7-9D23-E628068A846AQ34574712-AEAC5760-E1C7-4EE4-8A59-EFAEDE9C0AFFQ34654431-46234582-3986-4702-9264-CA3F933BBAACQ35010738-051ACF21-1950-4CF7-8813-C69B199C6841Q36011424-20587094-781E-49DB-9E17-F5BA0B348B3EQ36060718-6A2E9F08-CF12-40E3-8492-4A57EEA18763Q36085785-B8EBF9C7-67B4-4FA8-8ACE-AE766BD6872FQ36319332-DA1B2223-E5F9-4655-96A5-49A6644B1E97Q37363868-770EA30F-EB80-4025-AA29-2B166AA1C6FDQ37493594-0646731E-443A-4D4A-9EC9-B18C69221047Q37551787-2C59415B-3B6A-4557-96F1-2815FE4EC2FFQ37567077-DA45AFDE-330B-461E-B86C-51D1D9BAC4F1Q37827403-7F01C963-CB01-4E21-A8AC-EA3A6F7A9E3AQ38196629-253CC099-C0BD-4E7E-BBC3-9DE0C645A32BQ38388373-5C739492-51EE-4A5C-8EC9-5AE0A621A191Q38630775-E59065A5-00E5-426B-B507-D2A74DCA00A6Q38854339-59073F3D-F076-4E6B-A36F-53F99ED848F2Q39469525-92F1DDB3-2702-44F2-9631-042A464BF914Q39929591-058FF8DF-56EF-4B2A-B220-0BAE5A06CEE3Q40079604-F6F7D6D0-6664-4FDF-84C6-BE368A2F15D6Q40232367-A5525001-7263-4E38-8A99-0C320B36BAE8Q40255334-04A872BA-6AB8-4C21-9658-CE2198BA402BQ40284252-703A8C63-A9A3-43D3-9263-8B0C77E74F37Q40324345-F99B6B75-5465-4A24-9206-6F940AE134E6Q40334036-D5921D8F-6FB7-43FC-A0BD-CC18C71D08EBQ40334851-E7BF407F-518D-4C9E-838C-B34EDCDF7B64Q40597501-61F0D49C-176E-442F-835C-C06C05605F42Q40607323-97C98653-1C3D-4DEC-8975-66CE93D6EFAAQ40841412-C682FB50-1252-45D0-8F2D-1C079EBAE75EQ41533888-2D580F22-4AD3-42CB-95A5-B11D1447397DQ41641190-6CA55F9C-4A40-46A9-9DEE-4169F43CEE4FQ41745974-6E4E992D-8320-4F2A-81AD-E556FED3AE15Q41927578-DC9365BF-216F-42AC-A84C-DD924A8A2B14Q42063564-5C2616F1-BDBC-4E11-8BAC-CB09FD99C523Q43096554-303CAB76-AED6-4D21-8794-8D7C5338C40DQ43441691-3606CD6E-7D25-476C-9A26-275923840D8A
P50
description
forsker
@nb
researcher
@en
name
Shaye Kivity
@en
Shaye Kivity
@nb
Shaye Kivity
@nl
type
label
Shaye Kivity
@en
Shaye Kivity
@nb
Shaye Kivity
@nl
prefLabel
Shaye Kivity
@en
Shaye Kivity
@nb
Shaye Kivity
@nl
P106
P21
P31
P496
0000-0002-8391-5446